Richard M Heller

Nashville, TN, United States of America

Richard M Heller

USPTO Granted Patents = 43 

 


Average Co-Inventor Count = 2.9

ph-index = 13

Forward Citations = 1,002(Granted Patents)


Location History:

  • Nashville, TN (US) (1986 - 1992)
  • Brandon, FL (US) (1997 - 1998)
  • Temple Terrace, FL (US) (2000 - 2016)
  • Tampa, FL (US) (2001 - 2021)
  • Norfolk, VA (US) (2012 - 2023)

Company Filing History:


Years Active: 1986-2023

Loading Chart...
Loading Chart...
Loading Chart...
43 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Richard M Heller - Pioneering Cancer Treatment and Targeted Molecule Delivery

Introduction: Richard M Heller, a prolific inventor based in Nashville, TN, is making significant strides in the fields of oncology and targeted drug delivery. With an impressive portfolio of 43 patents, Heller's innovative approaches are revolutionizing cancer treatment and therapeutic molecule delivery systems.

Latest Patents:

1. Method for the Treatment of Malignancies: Heller's groundbreaking method involves injecting plasmids encoded for specific proteins into cancerous tumors and administering high-voltage, short-duration pulses to induce electroporation. This technique has shown promising results in tumor regression and the prevention of new tumor formation through immune memory response.

2. Targeted Delivery of Molecules Using Impedance-Based Monitoring at Elevated Temperatures: Heller's system focuses on delivering molecules to specific tissues by controlling temperature and impedance. By applying heat and administering electroporation pulses while monitoring impedance, this method allows for precise delivery of vaccines or therapeutics, including potential applications in fighting SARS-CoV-2 infections.

Career Highlights: Throughout his career, Richard M Heller has made significant contributions to the field of biomedical engineering. His work spans academic and research institutions, with notable positions in the University of South Florida and the Old Dominion University Research Foundation. Heller's dedication to pushing boundaries in medical innovation has led to transformative advancements in cancer therapy and targeted drug delivery systems.

Collaborations: In his research endeavors, Richard M Heller has collaborated with esteemed peers such as Mark Jeffrey Jaroszeski and Richard A Gilbert. These collaborations have further enriched Heller's innovative projects and have contributed to the successful development of cutting-edge technologies in the medical field.

Conclusion: Richard M Heller's pioneering spirit and dedication to advancing medical technologies have positioned him as a leading figure in the realms of oncology and targeted drug delivery. His patents and research breakthroughs not only showcase his expertise but also hold promise for improving the lives of countless individuals through innovative treatment approaches.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…